Skip to main content
PharmAbcine Inc. logo

PharmAbcine Inc. — Investor Relations & Filings

Ticker · 208340 ISIN · KR7208340000 KO Manufacturing
Open in API
Filings indexed 461 across all filing types
Latest filing 2021-08-05 Capital/Financing Update
Country KR South Korea
Listing KO 208340

About PharmAbcine Inc.

http://pharmabcine.com/

PharmAbcine Inc. is a clinical-stage biotechnology company specializing in the development of fully human therapeutic monoclonal antibodies (mAbs). The company focuses on creating innovative treatments for diseases with high unmet medical needs, primarily in oncology, neovascular eye diseases, and other inflammatory and vascular disorders. Utilizing its proprietary human antibody library and discovery technologies, PharmAbcine advances a pipeline of next-generation IgG-based therapeutics. The company's mission is to contribute to human health by providing novel antibody-based drugs to patients.

Recent filings

Filing Released Lang Actions
[기재정정]투자설명서
Capital/Financing Update Classification · 95% confidence The document is a '정정신고(보고)' (Amendment Report) for an '투자설명서' (Prospectus) filed with the Korean Financial Supervisory Service (DART). It details the finalization of the issuance price for a capital increase (share offering). According to the provided definitions, documents related to fundraising and capital structure changes are classified as 'CAP'. While it is a regulatory filing, 'CAP' is the most specific and accurate category for a prospectus amendment regarding share issuance pricing.
2021-08-05 Korean
주주명부폐쇄기간또는기준일설정
Share Issue/Capital Change Classification · 100% confidence The document is a short regulatory announcement from the company 'PharmAbcine' regarding the setting of a record date and shareholder register closure period for the purpose of a bonus issue (free share distribution). It is a standard regulatory disclosure filed with the KRX (Korea Exchange). Since it does not fit into specific categories like dividend announcements or share buybacks, and is a formal regulatory notice, it falls under the RNS category.
2021-08-04 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service (FSS) and Korea Exchange. This type of filing is a mandatory disclosure for directors and major shareholders regarding their personal shareholdings and changes therein, which corresponds to the 'Director's Dealing' category.
2021-08-03 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard South Korean regulatory disclosure (DART filing) where company insiders report changes in their shareholdings. This falls under the 'Director's Dealing' category as it details personal share transactions and ownership changes by a company executive (Choi Jun-hee).
2021-08-03 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service in South Korea. This type of filing is specifically used to disclose insider transactions (purchases/sales of shares or rights by directors/executives). According to the provided definitions, this falls under 'Director's Dealing' (DIRS).
2021-08-03 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean financial authorities (Financial Supervisory Service/KRX). This type of filing is specifically used to report insider transactions or changes in share ownership by company directors and executives. In the provided taxonomy, this corresponds to 'Director's Dealing' (DIRS).
2021-08-03 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.